Go to Client Portal

Regenerative Medicine

NAMSA has extensive experience with combination products, tissue/ biologics, regenerative medicine, cellular therapy and tissue engineering therapies. Our experience with these types of therapies is what has, in part, made us a premier contract research organization (CRO).

In addition, NAMSA’s highly skilled and experienced regulatory and quality consultants have a long history of successful submissions and practical, effective quality system development. We’ve conducted beneficial gap analyses and audits for regenerative medicine, cellular therapy and tissue engineering companies as well.

  • Extra Cellular Matrix
  • Regenerative Medicine
  • Cardiovascular
  • Urologic
  • Renal
  • Neurological
  • Orthopedic
  • Chondrocytes
  • Bone Healing
  • BMP
  • Pancreatic
  • Ophthalmologic
  • Dermal
  • Tissue Engineering
  • Xenotransplantation
  • Cellular Therapies
  • Exakt® Histological System for specialized tissue-hard implant processing
  • Quantitative Pathology
  • Biomarkers and immunohistochemistry
  • Ultrastructural Pathology (SEM, TEM)
  • Ostomy procedures
  • Anastomosis studies
  • Gastric reduction
  • Board Certified Veterinary Pathologists